Fig 1.
Flowchart summarizing literature search strategy and selection of studies.
Table 1.
The baseline characteristics of included studies.
Fig 2.
Forest plot of meta-analysis evaluating the proportion of MDSCs in HCC patients and healthy controls (A) or HCC patients and patients with chronic liver disease (B).
Fig 3.
Forest plot of subgroup meta-analysis evaluating the proportion of MDSCs by the phenotypes of MDSCs (A) and geographical areas (B) in HCC patients and healthy controls.
Fig 4.
Forest plot of meta-analysis evaluating the proportion of MDSCs before and after therapy in HCC patients.
Fig 5.
Forest plot of meta-analysis evaluating the relationship between MDSCs level and OS (A) or RFS/TTR (B) in HCC patients.
Table 2.
Main results for meta-analysis between MDSC and clinicopathological factors.
Fig 6.
Funnel plot of publication bias for the studies evaluating MDSCs proportion in HCC patients and healthy controls.
(A), treatment effect (B), and overall survival (C).